(HZO) MarineMax - Overview
Stock: Boats, Yachts, Parts, Services, Finance
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 62.7% |
| Relative Tail Risk | -18.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.17 |
| Alpha | -22.56 |
| Character TTM | |
|---|---|
| Beta | 1.658 |
| Beta Downside | 1.564 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.62% |
| CAGR/Max DD | -0.02 |
Description: HZO MarineMax December 26, 2025
MarineMax, Inc. (NYSE:HZO) is the United States’ largest retailer of recreational boats and yachts, operating through Retail Operations and Product Manufacturing segments. The company sells a broad portfolio that includes new and used pleasure, fishing, and mega-yachts, as well as pontoon, ski, jet, and e-power boats, complemented by a full line of marine parts, accessories, and related services such as financing, insurance, brokerage, and charter operations. It also runs a vacation business in the British Virgin Islands and reaches customers via off-site locations and print catalogs.
Key recent metrics (FY 2023) show total revenue of approximately $2.2 billion, a 6 % same-store sales increase, and an average transaction value of roughly $45 k, reflecting strong demand for higher-priced vessels. The company’s inventory turnover improved to 4.2×, indicating better stock management, while its financing arm generated $150 million in net interest income, underscoring the importance of consumer credit conditions.
Sector drivers that materially affect MarineMax include discretionary consumer spending trends, which are sensitive to macro-economic factors such as employment growth and confidence indices; the prevailing interest-rate environment, which influences boat-loan affordability; and fuel-price volatility, which can shift buyer preferences toward more fuel-efficient e-power or hybrid models. Additionally, the broader marine leisure market benefits from a “stay-cation” shift that has boosted domestic boating activity post-COVID-19.
For a deeper quantitative perspective, the ValueRay HZO report provides a data-rich framework to evaluate the stock’s risk-adjusted upside.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: -57.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 13.23 > 1.0 |
| NWC/Revenue: 7.81% < 20% (prev 8.73%; Δ -0.92% < -1%) |
| CFO/TA 0.10 > 3% & CFO 235.8m > Net Income -57.6m |
| Net Debt (676.7m) to EBITDA (106.7m): 6.34 < 3 |
| Current Ratio: 1.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.9m) vs 12m ago -6.17% < -2% |
| Gross Margin: 31.59% > 18% (prev 0.34%; Δ 3125 % > 0.5%) |
| Asset Turnover: 92.68% > 50% (prev 90.05%; Δ 2.63% > 0%) |
| Interest Coverage Ratio: 0.94 > 6 (EBITDA TTM 106.7m / Interest Expense TTM 68.3m) |
Altman Z'' 2.18
| A: 0.08 (Total Current Assets 1.14b - Total Current Liabilities 961.3m) / Total Assets 2.43b |
| B: 0.30 (Retained Earnings 738.5m / Total Assets 2.43b) |
| C: 0.03 (EBIT TTM 64.1m / Avg Total Assets 2.53b) |
| D: 0.50 (Book Value of Equity 746.7m / Total Liabilities 1.48b) |
| Altman-Z'' Score: 2.18 = BBB |
Beneish M -3.08
| DSRI: 1.04 (Receivables 85.9m/83.3m, Revenue 2.35b/2.37b) |
| GMI: 1.06 (GM 31.59% / 33.53%) |
| AQI: 0.99 (AQ_t 0.25 / AQ_t-1 0.25) |
| SGI: 0.99 (Revenue 2.35b / 2.37b) |
| TATA: -0.12 (NI -57.6m - CFO 235.8m) / TA 2.43b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
What is the price of HZO shares?
Over the past week, the price has changed by +19.19%, over one month by +19.53%, over three months by +21.15% and over the past year by -3.83%.
Is HZO a buy, sell or hold?
- StrongBuy: 6
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HZO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.7 | 7.8% |
| Analysts Target Price | 31.7 | 7.8% |
| ValueRay Target Price | 31.7 | 7.7% |
HZO Fundamental Data Overview February 01, 2026
P/S = 0.252
P/B = 0.5779
P/EG = 0.62
Revenue TTM = 2.35b USD
EBIT TTM = 64.1m USD
EBITDA TTM = 106.7m USD
Long Term Debt = 347.5m USD (from longTermDebt, last quarter)
Short Term Debt = 713.5m USD (from shortTermDebt, last quarter)
Debt = 841.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 676.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.27b USD (591.1m + Debt 841.3m - CCE 164.6m)
Interest Coverage Ratio = 0.94 (Ebit TTM 64.1m / Interest Expense TTM 68.3m)
EV/FCF = 6.87x (Enterprise Value 1.27b / FCF TTM 184.7m)
FCF Yield = 14.57% (FCF TTM 184.7m / Enterprise Value 1.27b)
FCF Margin = 7.87% (FCF TTM 184.7m / Revenue TTM 2.35b)
Net Margin = -2.46% (Net Income TTM -57.6m / Revenue TTM 2.35b)
Gross Margin = 31.59% ((Revenue TTM 2.35b - Cost of Revenue TTM 1.60b) / Revenue TTM)
Gross Margin QoQ = 31.77% (prev 34.67%)
Tobins Q-Ratio = 0.52 (Enterprise Value 1.27b / Total Assets 2.43b)
Interest Expense / Debt = 1.88% (Interest Expense 15.9m / Debt 841.3m)
Taxrate = 21.0% (US default 21%)
NOPAT = 50.6m (EBIT 64.1m * (1 - 21.00%))
Current Ratio = 1.19 (Total Current Assets 1.14b / Total Current Liabilities 961.3m)
Debt / Equity = 0.90 (Debt 841.3m / totalStockholderEquity, last quarter 932.8m)
Debt / EBITDA = 6.34 (Net Debt 676.7m / EBITDA 106.7m)
Debt / FCF = 3.66 (Net Debt 676.7m / FCF TTM 184.7m)
Total Stockholder Equity = 951.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.28% (Net Income -57.6m / Total Assets 2.43b)
RoE = -6.06% (Net Income TTM -57.6m / Total Stockholder Equity 951.0m)
RoCE = 4.94% (EBIT 64.1m / Capital Employed (Equity 951.0m + L.T.Debt 347.5m))
RoIC = 2.43% (NOPAT 50.6m / Invested Capital 2.08b)
WACC = 5.84% (E(591.1m)/V(1.43b) * Re(12.03%) + D(841.3m)/V(1.43b) * Rd(1.88%) * (1-Tc(0.21)))
Discount Rate = 12.03% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.92%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈184.7m ; Y1≈121.2m ; Y5≈55.3m
Fair Price DCF = 49.65 (EV 1.76b - Net Debt 676.7m = Equity 1.09b / Shares 21.9m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -83.79 | EPS CAGR: -61.64% | SUE: -0.24 | # QB: 0
Revenue Correlation: -17.31 | Revenue CAGR: -4.91% | SUE: 0.56 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.14 | Chg30d=-0.002 | Revisions Net=+0 | Analysts=6
EPS current Year (2026-09-30): EPS=0.71 | Chg30d=+0.007 | Revisions Net=-5 | Growth EPS=+15.8% | Growth Revenue=+1.9%
EPS next Year (2027-09-30): EPS=1.68 | Chg30d=-0.023 | Revisions Net=-2 | Growth EPS=+138.4% | Growth Revenue=+3.9%